Share Search
Visit the Share Search
Immupharma Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | n/a | n/a | n/a | n/a | 0.12 |
| Operating Profit / Loss | -2.53 | -2.68 | -3.06 | -3.03 | -6.59 |
| Net Interest | 0.36 | -0.10 | -0.36 | -1.43 | -2.35 |
| Pre Tax Profit | -2.17 | -2.78 | -3.42 | -4.46 | -8.94 |
| Post Tax Profit | -1.81 | -2.48 | -2.92 | -3.81 | -8.17 |
| Profit for the Period | -1.81 | -2.48 | -2.92 | -3.81 | -8.17 |
| Equity Holders of Parent Company | -1.81 | -2.48 | -2.92 | -3.81 | -8.17 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -0.37p | -0.60p | -0.81p | -1.26p | -3.25p |
| Earnings per Share (Diluted) | -0.37p | -0.60p | -0.81p | -1.26p | -3.25p |
| Earnings per Share (Adjusted) | -0.37p | -0.60p | -0.81p | -1.26p | -3.25p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -0.37p | -0.60p | -0.81p | -1.26p | -3.25p |
| Earnings per Share (Diluted) | -0.37p | -0.60p | -0.81p | -1.26p | -3.25p |
| Earnings per Share (Adjusted) | -0.37p | -0.60p | -0.81p | -1.26p | -3.25p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | n/a | 0.01 | 0.45 | 0.47 | 0.48 |
| Property, Plant and Equipment | 0.06 | 0.08 | 0.10 | 0.39 | 0.35 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | 0.83 | 0.69 | 1.42 |
| Other Non-Current Assets | n/a | n/a | n/a | 0.08 | 0.41 |
| Total Non-Current Assets | 0.06 | 0.09 | 1.38 | 1.64 | 2.65 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 0.17 | 0.25 | 0.47 | 0.72 | 0.43 |
| Cash at Bank and in Hand | 1.35 | 0.24 | 0.21 | 0.67 | 1.65 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 0.29 | 0.39 | 0.67 | 0.95 | 1.27 |
| Total Current Assets | 1.81 | 0.88 | 1.34 | 2.34 | 3.35 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 1.88 | 0.98 | 2.72 | 3.98 | 6.00 |
| Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | 0.00 |
| Other Current Liabilities | 1.19 | 1.52 | 1.67 | 1.45 | 1.58 |
| Total Current Liabilities | 1.19 | 1.52 | 1.67 | 1.45 | 1.58 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Net Assets | 0.69 | -0.54 | 1.06 | 2.52 | 4.41 |
| Capital and Reserves | |||||
| Share Capital | 30.68 | 29.81 | 29.81 | 28.98 | 28.50 |
| Share Premium Account | 31.36 | 29.32 | 29.32 | 28.79 | 27.24 |
| Other Reserves | 6.37 | 6.24 | 6.01 | 5.87 | 5.26 |
| Retained Earnings | -67.72 | -65.91 | -64.08 | -61.12 | -56.58 |
| Shareholders Funds | 0.69 | -0.54 | 1.06 | 2.52 | 4.41 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 0.69 | -0.54 | 1.06 | 2.52 | 4.41 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | n/a% | n/a% | n/a% | n/a% | -5,565.66% |
| Return on Capital Employed | n/a% | n/a% | n/a% | n/a% | n/a% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 0.11p | -0.09p | 0.10p | 0.33p | 0.63p |